Abstract
Bronchiectasis remains common in indigenous populations as reported from Alaska, Australia and New Zealand. Each of these countries has published incidence and prevalence estimates, suggested aetiologies, clinical course and associated factors which may contribute to the burden of disease. The purpose of this collaborative review is to summarise literature on bronchiectasis in indigenous peoples, discuss similarities and differences between these groups and countries, and compare these findings to recent reports on non-indigenous populations. Difficulties in applying best management practice are highlighted, including the difficult and confusing terminology, and suggestions made to address the unmet healthcare needs in order to reduce future respiratory morbidity and mortality in these populations.
Keywords: Indigenous, bronchiectasis, chronic cough, pneumonia, poverty, children, chronic respiratory disease
Current Pediatric Reviews
Title: Burden of Bronchiectasis in Indigenous Peoples - How Can it be Improved?
Volume: 5 Issue: 4
Author(s): Karen Munro, Rosalyn J. Singleton, Elizabeth A. Edwards, Gregory J. Redding, Anne B. Chang and Catherine A. Byrnes
Affiliation:
Keywords: Indigenous, bronchiectasis, chronic cough, pneumonia, poverty, children, chronic respiratory disease
Abstract: Bronchiectasis remains common in indigenous populations as reported from Alaska, Australia and New Zealand. Each of these countries has published incidence and prevalence estimates, suggested aetiologies, clinical course and associated factors which may contribute to the burden of disease. The purpose of this collaborative review is to summarise literature on bronchiectasis in indigenous peoples, discuss similarities and differences between these groups and countries, and compare these findings to recent reports on non-indigenous populations. Difficulties in applying best management practice are highlighted, including the difficult and confusing terminology, and suggestions made to address the unmet healthcare needs in order to reduce future respiratory morbidity and mortality in these populations.
Export Options
About this article
Cite this article as:
Munro Karen, J. Singleton Rosalyn, A. Edwards Elizabeth, J. Redding Gregory, B. Chang Anne and A. Byrnes Catherine, Burden of Bronchiectasis in Indigenous Peoples - How Can it be Improved?, Current Pediatric Reviews 2009; 5 (4) . https://dx.doi.org/10.2174/157339609791317342
DOI https://dx.doi.org/10.2174/157339609791317342 |
Print ISSN 1573-3963 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6336 |
Call for Papers in Thematic Issues
Early-life nutrition: impacts on health and diseases
In early life, organs and hormonal axes are especially susceptible to changes that can affect the intestinal mucosa, immune system, and long-term health. Critical factors in the developmental process, including maternal diet, type of delivery, breastfeeding, and the nutritional status of mothers and children, have gained prominence. Evidence suggests that ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Going up in Smoke? A Review of nAChRs-based Treatment Strategies for Improving Cognition in Schizophrenia
Current Pharmaceutical Design Induced Pluripotent Stem Cell-Based Studies of Parkinson's Disease: Challenges and Promises
CNS & Neurological Disorders - Drug Targets Biphasic Mechanisms of Neurovascular Unit Injury and Protection in CNS Diseases
CNS & Neurological Disorders - Drug Targets Pharmacodynamics of Memantine: An Update
Current Neuropharmacology Stem Cell Therapy for Alzheimers Disease
CNS & Neurological Disorders - Drug Targets Pharmacoproteomics Applications for Drug Target Discovery in CNS Disorders
Current Pharmacogenomics and Personalized Medicine The Future of Neuroregenerative Therapy for Parkinson’s Disease
Current Tissue Engineering (Discontinued) Serotonin Receptor Binding Characteristics of Geissoschizine Methyl Ether, an Indole Alkaloid in Uncaria Hook
Current Medicinal Chemistry Evaluating Drug Safety in Children and Adolescents with Bipolar Disorder
Current Drug Safety Therapeutic Potential, Synthesis, Patent Evaluation and SAR Studies of Thieno[3,2-d]pyrimidine Derivatives: Recent Updates
Current Drug Targets Cannabinoids for the Treatment of Schizophrenia: An Overview
Current Topics in Medicinal Chemistry The Concept of “Neuroprotection” in Neurological Diseases
Current Neuropharmacology Structural Properties of the NMDA Receptor and the Design of Neuroprotective Therapies
Mini-Reviews in Medicinal Chemistry Central Nervous System Depressants and Risk of Hospitalization due to Community-Acquired Pneumonia in very Old Patients
Current Drug Safety NOS: Molecular Mechanisms, Clinical Aspects, Therapeutic and Monitoring Approaches
Current Drug Targets - Inflammation & Allergy Neuroregeneration in Parkinson’s Disease: From Proteins to Small Molecules
Current Neuropharmacology Endocannabinoid Metabolic Pathways and Enzymes
Current Drug Targets - CNS & Neurological Disorders Non-viral Gene Delivery and Therapeutics Targeting to Brain
Current Nanoscience Neurotoxicity: The Broad Framework of Electron Transfer, Oxidative Stress and Protection by Antioxidants
Current Medicinal Chemistry - Central Nervous System Agents Pharmacological Aspects of (-)-Deprenyl
Current Medicinal Chemistry